Skip to main content
Dryad

Data from: Deep mutational scanning of the multi-domain phosphatase SHP2 reveals mechanisms of regulation and pathogenicity

Data files

May 18, 2024 version files 69.19 GB
Jul 11, 2024 version files 95.84 GB
Jan 07, 2025 version files 95.84 GB
Mar 25, 2025 version files 95.89 GB

Select up to 11 GB of files for download

Abstract

Multi-domain enzymes can be regulated both by inter-domain interactions and structural features intrinsic to the catalytic domain. The tyrosine phosphatase SHP2 is a quintessential example of a multi-domain protein that is regulated by inter-domain interactions. This enzyme has a protein tyrosine phosphatase (PTP) domain and two phosphotyrosine-recognition domains (N-SH2 and C-SH2) that regulate phosphatase activity through autoinhibitory interactions. SHP2 is canonically activated by phosphoprotein binding to the SH2 domains, which causes large interdomain rearrangements, but autoinhibition is also disrupted by disease-associated mutations. Many details of the SHP2 activation are still unclear, the structure of the active state remains elusive, and hundreds of human variants of SHP2 have not been functionally characterized. Here, we perform scanning mutagenesis on both full-length SHP2 and its isolated PTP domain to examine mutational effects on inter-domain regulation and catalytic activity. Our experiments provide a comprehensive map of SHP2 mutational sensitivity, both in the presence and absence of interdomain regulation. Coupled with molecular dynamics simulations, our investigation reveals novel structural features that govern the stability of the autoinhibited and active states of SHP2. Our analysis also identifies key residues beyond the SHP2 active site that control PTP domain dynamics and intrinsic catalytic activity. This work expands our understanding of SHP2 regulation and provides new insights into SHP2 pathogenicity.